Advancements in melanoma immunotherapy: the emergence of Extracellular Vesicle Vaccines
Open Access
- 23 August 2024
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-12
Abstract
Malignant melanoma represents a particularly aggressive type of skin cancer, originating from the pathological transformation of melanocytes. While conventional interventions such as surgical resection, chemotherapy, and radiation therapy are available, their non-specificity and collateral damage to normal cells has shifted the focus towards immunotherapy as a notable approach. Extracellular vesicles (EVs) are naturally occurring transporters, and are capable of delivering tumor-specific antigens and directly engaging in the immune response. Multiple types of EVs have emerged as promising platforms for melanoma vaccination. The effectiveness of EV-based melanoma vaccines manifests their ability to potentiate the immune response, particularly by activating dendritic cells (DCs) and CD8+ T lymphocytes, through engineering a synergy of antigen presentation and targeted delivery. Here, this review mainly focuses on the construction strategies for EV vaccines from various sources, their effects, and immunological mechanisms in treating melanoma, as well as the shortcomings and future perspectives in this field. These findings will provide novel insights into the innovative exploitation of EV-based vaccines for melanoma immune therapy.Keywords
This publication has 142 references indexed in Scilit:
- Extracellular vesicles originating from melanoma cells promote dysregulation in haematopoiesis as a component of cancer immunoeditingJournal of Extracellular Vesicles, 2024
- Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editingJournal of Extracellular Vesicles, 2023
- Tumor vaccine based on extracellular vesicles derived from γδ‐T cells exerts dual antitumor activitiesJournal of Extracellular Vesicles, 2023
- A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancerCancer Medicine, 2022
- Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodesJournal of Extracellular Vesicles, 2022
- Quantification of protein cargo loading into engineered extracellular vesicles at single‐vesicle and single‐molecule resolutionJournal of Extracellular Vesicles, 2021
- Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapyJournal of Extracellular Vesicles, 2021
- Engineered Extracellular Vesicles for Cancer TherapyAdvanced Materials, 2021
- Tumor‐derived exosomes (TDEs): How to avoid the sting in the tailMedicinal Research Reviews, 2019
- Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapyBiotechnology Letters, 2016